Literature DB >> 6438672

Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

R R Griffiths, D R McLeod, G E Bigelow, I A Liebson, J D Roache.   

Abstract

The effects of diazepam (10-160 mg) and oxazepam (30-480 mg) were studied in volunteers with histories of drug abuse. Oral doses were administered every third day under double-blind and counterbalanced conditions. Dose-effects with area under the time-action curve data (AUC) showed diazepam to be 2.6-5.7-times more potent than oxazepam on various psychomotor, cognitive, staff-rated, and subjective measures. Comparison of relative potencies showed diazepam to be relatively more potent in producing 'liking' than in producing psychomotor and cognitive effects. Diazepam produced greater peak effects than oxazepam on a number of staff- and subject-rated measures, including liking. Onset of effect was more rapid and time to maximal effect was shorter (1-2 h versus 4-12 h) with diazepam than oxazepam, while time to offset of effect was similar for the two drugs. Diazepam was categorized as producing barbiturate-like subjective effects (38.3%) more frequently than was oxazepam (13.8%), while oxazepam was identified as placebo more often than diazepam. Repeated administration of 160 mg diazepam and 480 mg oxazepam showed that AUC liking was greater for diazepam than oxazepam and that tolerance to psychomotor and cognitive effects occurred with oxazepam but not diazepam. This study suggests that diazepam may have a higher abuse liability than oxazepam.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438672     DOI: 10.1007/bf00427437

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

Review 1.  Internal stimulus control and subjective effects of drugs.

Authors:  C R Schuster; M W Fischman; C E Johanson
Journal:  NIDA Res Monogr       Date:  1981-07

Review 2.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

3.  [The addiction potential of benzodiazepines. Application of the results of treatment of alcohol withdrawal syndrome].

Authors:  L Walters; P Nel
Journal:  S Afr Med J       Date:  1981-01-24

4.  Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.

Authors:  R R Griffiths; G E Bigelow; I Liebson; J E Kaliszak
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

5.  Differential effects of diazepam and pentobarbital on mood and behavior.

Authors:  R R Griffiths; G E Bigelow; I Liebson
Journal:  Arch Gen Psychiatry       Date:  1983-08

6.  Physical dependence on diazepam and lorazepam in the dog.

Authors:  L F McNicholas; W R Martin; S Cherian
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

7.  Benzodiazepine withdrawal effects.

Authors:  J C Pecknold; D J McClure; D Fleuri; H Chang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

8.  Assessment of the abuse liability of buspirone in recreational sedative users.

Authors:  J O Cole; M H Orzack; B Beake; M Bird; Y Bar-Tal
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

9.  Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam.

Authors:  C Salzman; R I Shader; D J Greenblatt; J S Harmatz
Journal:  Arch Gen Psychiatry       Date:  1983-03

10.  Oxazepam in the treatment of anxiety associated with depression: results of treatment in 1600 cases (Studies in depression, VI).

Authors:  H R Bailey; E Davies; I J Morrison
Journal:  Curr Med Res Opin       Date:  1981       Impact factor: 2.580

View more
  18 in total

1.  On the differences in psychotropic drug use between the three major urban areas in Sweden.

Authors:  A Wessling; U Bergman; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

5.  A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepam.

Authors:  Ingunn Fride Tvete; Trine Bjørner; Tor Skomedal
Journal:  Br J Gen Pract       Date:  2016-03-10       Impact factor: 5.386

6.  The behavioral actions of diazepam and oxazepam are similar.

Authors:  S P Mewaldt; M M Ghoneim; J V Hinrichs
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Discriminative stimulus effects of diazepam and buspirone in normal volunteers.

Authors:  C R Rush; T S Critchfield; J R Troisi; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1995-05       Impact factor: 2.468

8.  Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

Authors:  S J Heishman; J E Henningfield
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 9.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Alprazolam and oxazepam block the cue-induced reinstatement of extinguished cocaine seeking in rats.

Authors:  Nicholas E Goeders; David M Clampitt; Courtney Keller; Mukesh Sharma; Glenn F Guerin
Journal:  Psychopharmacology (Berl)       Date:  2008-09-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.